---
document_datetime: 2023-09-21 17:21:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/somavert-epar-all-authorised-presentations_en.pdf
document_name: somavert-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.2540598
conversion_datetime: 2025-12-15 00:28:42.782543
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration Immediate packaging Content (concentration) Pack size

| EU/1/02/240/001   | Somavert   | 10 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 10 mg; solvent: 1 ml   | 30 vials + 30 pre-filled syringes   |
|-------------------|------------|---------|-------------------------------------------------|--------------------|-------------------------------------------------------------|--------------------------------|-------------------------------------|
| EU/1/02/240/002   | Somavert   | 15 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 15 mg; solvent: 1 ml   | 30 vials + 30 pre-filled syringes   |
| EU/1/02/240/003   | Somavert   | 20 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 20 mg; solvent: 1 ml   | 30 vials + 30 pre-filled syringes   |
| EU/1/02/240/004   | Somavert   | 20 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 20 mg; solvent: 1 ml   | 1 vial + 1 pre-filled syringe       |
| EU/1/02/240/009   | Somavert   | 25 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 25 mg; solvent: 1 ml   | 1 vial + 1 pre-filled syringe       |
| EU/1/02/240/010   | Somavert   | 25 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 25 mg; solvent: 1 ml   | 30 vials + 30 pre-filled syringes   |
| EU/1/02/240/011   | Somavert   | 30 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe (glass)   | Powder: 30 mg; solvent: 1 ml   | 1 vial + 1 pre-filled syringe       |
| EU/1/02/240/012   | Somavert   | 30 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Powder: vial (glass); solvent: pre-filled syringe(glass)    | Powder: 30 mg solvent: 1 ml    | 30 vials + 30 pre-filled syringes   |